The Food and Drug Administration (FDA) has recently released a statement detailing a link between the drug Fosamax and the development of esophageal cancer. Fosamax is used to treat osteoporosis in women and is manufactured by pharmaceutical giant Merk.
Since Fosamax was approved for use in 1995, there have been 23 cases of patients developing esophageal tumors. In most cases, patients were diagnosed with cancer within two years of first taking Fosamax. Eight of the 23 patients have died so far.
There have also been 21 cases of Fosamax patients developing esophageal cancer in Europe and Japan. Six of these patients have already died. While this evidence is very strong, the FDA is still calling for further research to more conclusively establish this link. Currently, there is no recall for the drug.
This is not the first side effect reported related to an esophageal condition. For years, Fosamax has been known to cause esophagitis, an inflammation of the lining of the esophagus. Patients with a history of acid reflux disease should consult their doctor before taking Fosamax, since they may be at increased risk of harmful side effects.
Fosamax patients who have suffered a harmful condition from taking the drug should consult an experienced pharmaceutical injury attorney at once. You may be eligible to receive compensation for your injuries.
If you live in the Phoenix, Arizona area and have a dangerous drug claim involving Fosamax, please contact the law offices of Snyder & Wenner, P.C. today to schedule an initial consultation.
